Cite Filings / REVB / 0001193125-25-256367

Feed Companies Filings Check

Sign in

8-K

Current Report

REVELATION BIOSCIENCES, INC. Filed 2025-10-29 Acc 0001193125-25-256367

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , revb-20251029.htm

Around this filing

2025-11-06 8-K Results of operations
2025-10-31 4 Director acquired 15,625 shares (grant or award)
2025-10-31 4 Chief Executive Officer acquired 390,614 shares (grant or award)
2025-10-31 4 Director acquired 15,625 shares (grant or award)
2025-10-30 PRE 14A Proxy Statement (Preliminary)
2025-10-29 8-K Regulation FD disclosure
2025-10-15 8-K Regulation FD disclosure

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading revb-20251029.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…